menu ☰
menu ˟

VIDEO: MARIANNE trial results improve quality of life, reduce toxicities

19 Aug 2015
CHICAGO – The addition of pertuzumab to T-DM1 therapy did not improve PFS but enhanced quality of life and reduced toxicity among women with HER-2–positive advanced breast cancer, according to study results presented at the 2015 ASCO Annual Meeti...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.